GSTM1 and beta thalassemia: Several studies have suggested the limitation of Hb level as a clinical decision indicator for starting transfusion dependent management [30] since there were only minor differences in Hb levels (1.8–2.6 g/dl) between the mildest and most severe forms of HbE beta thalassemia.